2-[(4R)-4-amino-8-azaspiro[4.5]decan-8-yl]-5-(2,3-dichlorophenyl)-6-methylpyrimidine-4-carboxamide
C21H25Cl2N5O — CID 155095691
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[(4R)-4-amino-8-azaspiro[4.5]decan-8-yl]-5-(2,3-dichlorophenyl)-6-methylpyrimidine-4-carboxamide
2-[(4R)-4-amino-8-azaspiro[4.5]decan-8-yl]-5-(2,3-dichlorophenyl)-6-methylpyrimidine-4-carboxamide (PubChem CID 155095691) has the molecular formula C21H25Cl2N5O and a molecular weight of 434.37 g/mol. Its IUPAC name is 2-[(4R)-4-amino-8-azaspiro[4.5]decan-8-yl]-5-(2,3-dichlorophenyl)-6-methylpyrimidine-4-carboxamide.
Molecular Properties
| Compound Name | 2-[(4R)-4-amino-8-azaspiro[4.5]decan-8-yl]-5-(2,3-dichlorophenyl)-6-methylpyrimidine-4-carboxamide |
|---|---|
| PubChem CID | 155095691 |
| Molecular Formula | C21H25Cl2N5O |
| Molecular Weight | 434.37 g/mol |
| Exact Mass | 433.14 |
| IUPAC Name | 2-[(4R)-4-amino-8-azaspiro[4.5]decan-8-yl]-5-(2,3-dichlorophenyl)-6-methylpyrimidine-4-carboxamide |
| SMILES | Cc1nc(N2CCC3(CCC[C@H]3N)CC2)nc(C(N)=O)c1-c1cccc(Cl)c1Cl |
| InChI | InChI=1S/C21H25Cl2N5O/c1-12-16(13-4-2-5-14(22)17(13)23)18(19(25)29)27-20(26-12)28-10-8-21(9-11-28)7-3-6-15(21)24/h2,4-5,15H,3,6-11,24H2,1H3,(H2,25,29)/t15-/m1/s1 |
| InChIKey | ZULOETSIOFVBBP-OAHLLOKOSA-N |
| XLogP | 3.96 |
| TPSA | 98.13 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.37 |
| LogP ≤ 5 | 3.96 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155095691 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.